BioTime Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,434.30
5,243.20
7,036.00
5,923.00
3,458.00
1,416
Cost of Goods Sold (COGS) incl. D&A
4,745.10
9,247.40
7,441.00
5,115.00
3,464.00
3,575
Gross Income
310.80
4,004.20
405.00
808.00
6.00
2,159
SG&A Expense
38,215.60
46,678.40
65,404.00
59,775.00
40,650.00
42,408
EBIT
38,526.40
50,682.60
-
58,967.00
40,656.00
44,567
Unusual Expense
17,458.80
-
-
-
14,856.00
8,746
Non Operating Income/Expense
207.20
383.60
3,534.00
48,645.00
3,203.00
5,472
Interest Expense
-
91.00
340.00
747.00
692.00
-
Pretax Income
56,189.80
51,154.70
62,650.00
18,621.00
23,289.00
47,130
Income Tax
3,280.70
7,375.60
4,516.00
-
-
346
Consolidated Net Income
52,909.10
43,779.10
58,134.00
18,621.00
23,289.00
46,784
Net Income
43,882.80
36,411.70
46,991.00
33,572.00
19,976.00
45,990
Net Income After Extraordinaries
43,882.80
36,411.70
46,991.00
33,572.00
19,976.00
45,990
Net Income Available to Common
43,882.80
36,498.50
47,406.00
33,572.00
19,976.00
45,990
EPS (Basic)
0.81
0.55
0.59
0.34
0.17
0.36
Basic Shares Outstanding
54,226.20
66,466.70
79,711.00
97,316.00
114,476.00
126,903
EPS (Diluted)
0.81
0.55
0.59
0.34
0.17
0.36
Diluted Shares Outstanding
54,226.20
66,466.70
79,711.00
99,553.00
114,476.00
126,903
EBITDA
34,573.90
42,272.20
59,475.00
54,210.00
37,360.00
41,294
Non-Operating Interest Income
2.50
2.60
-
-
-
711
Minority Interest Expense
9,026.30
7,367.40
11,143.00
14,951.00
3,313.00
794
Equity in Affiliates (Pretax)
-
-
35.00
29,690.00
-
-
Preferred Dividends
-
86.80
415.00
-
-
-
About BioTime
View Profile
